Page 14 - அமெரிக்கன் சங்கம் க்கு புற்றுநோய் ஆராய்ச்சி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Novel therapeutic agent could be effective for treating cancers with certain gene mutations Mount Sinai researchers have developed a therapeutic agent that shows high effectiveness in vitro at disrupting a biological pathway that helps cancer survive, according to a paper published in Cancer Discovery, a journal of the American Association for Cancer Research, in July. The therapy is an engineered molecule, named MS21, that causes the degradation of AKT, an enzyme that is overly active in many cancers. This study laid out evidence that pharmacological degradation of AKT is a viable treatment for cancers with mutations in certain genes. Related Stories

United statesJian jinRamon parsonsEmily hendersonCancer researchAmerican association for cancer researchIcahn school of medicine at mount sinaiTisch cancer instituteMount sinai centerOncological sciencesCancer discoveryAmerican associationWard coleman chairIcahn schoolMount sinai professorTherapeutics discovery